enVVeno Medical Statistics
Total Valuation
enVVeno Medical has a market cap or net worth of $6.13 million. The enterprise value is -$24.03 million.
Important Dates
The next estimated earnings date is Friday, February 27, 2026, before market open.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
enVVeno Medical has 655,606 shares outstanding. The number of shares has increased by 27.53% in one year.
| Current Share Class | 655,606 |
| Shares Outstanding | 655,606 |
| Shares Change (YoY) | +27.53% |
| Shares Change (QoQ) | -0.97% |
| Owned by Insiders (%) | 4.04% |
| Owned by Institutions (%) | 9.59% |
| Float | 504,345 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.18 |
| P/TBV Ratio | 0.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.12, with a Debt / Equity ratio of 0.03.
| Current Ratio | 13.12 |
| Quick Ratio | 12.90 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.19% and return on invested capital (ROIC) is -36.90%.
| Return on Equity (ROE) | -57.19% |
| Return on Assets (ROA) | -35.12% |
| Return on Invested Capital (ROIC) | -36.90% |
| Return on Capital Employed (ROCE) | -77.62% |
| Weighted Average Cost of Capital (WACC) | 8.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$593,649 |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.81% in the last 52 weeks. The beta is 1.04, so enVVeno Medical's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -91.81% |
| 50-Day Moving Average | 11.78 |
| 200-Day Moving Average | 71.19 |
| Relative Strength Index (RSI) | 38.52 |
| Average Volume (20 Days) | 28,302 |
Short Selling Information
| Short Interest | 2.14M |
| Short Previous Month | 2.11M |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.25M |
| Pretax Income | -21.97M |
| Net Income | -21.97M |
| EBITDA | -23.11M |
| EBIT | -23.25M |
| Earnings Per Share (EPS) | -$37.85 |
Full Income StatementBalance Sheet
The company has $30.95 million in cash and $791,000 in debt, with a net cash position of $30.16 million or $46.00 per share.
| Cash & Cash Equivalents | 30.95M |
| Total Debt | 791,000 |
| Net Cash | 30.16M |
| Net Cash Per Share | $46.00 |
| Equity (Book Value) | 29.45M |
| Book Value Per Share | 50.98 |
| Working Capital | 29.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$17.23 million and capital expenditures -$9,000, giving a free cash flow of -$17.24 million.
| Operating Cash Flow | -17.23M |
| Capital Expenditures | -9,000 |
| Free Cash Flow | -17.24M |
| FCF Per Share | -$26.29 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
